| HOME >> MEDICINE >> TECHNOLOGY |
Table 55: Specialty Pharmaceutical Market, Epilepsy, Global, Annual Cost of Therapy ($), 2009-2017 84
Table 56: Specialty Pharmaceutical Market, Epilepsy, Global, Usage Patterns, 2001–2009 85
Table 57: Specialty Pharmaceutical Market, Epilepsy, Global, Usage Patterns, 2009–2017 85
Table 58: Specialty Pharmaceutical Market, Glaucoma, Global, Revenue ($m), 2001-2009 92
Table 59: Specialty Pharmaceutical Market, Glaucoma, Global, Revenue ($m), 2009-2017 92
Table 60: Specialty Pharmaceutical Market, Epilepsy, Global, Geographical Distribution of Revenues ($m), 2001–2009 93
Table 61: Specialty Pharmaceutical Market, Epilepsy, Global, Geographical Distribution of Revenues ($m), 2009–2017 93
Table 62: Specialty Pharmaceutical Market, Glaucoma, Global, Annual Cost of Therapy ($), 2001-2009 94
Table 63: Specialty Pharmaceutical Market, Epilepsy, Global, Annual Cost of Therapy ($), 2009-2017 94
Table 64: Specialty Pharmaceutical Market, Glaucoma, Global, Usage Patterns, 2001–2009 95
Table 65: Specialty Pharmaceutical Market, Glaucoma, Global, Usage Patterns, 2009–2017 96
Table 66: Specialty Pharmaceutical Market, M&A, Pfizer, 2004 to 2010 144
Table 67: Specialty Pharmaceutical Market, M&A, F. Hoffmann-La Roche, 2004 to 2010 146
Table 68: Specialty Pharmaceutical Market, M&A, GlaxoSmithKline, 2004 to 2010 146
Table 69: Specialty Pharmaceutical Market, Licensing Deals, Pfizer, 2004 to 2010 149
Table 70: Specialty Pharmaceutical Market, Licensing Deals , F. Hoffmann-La Roche, 2004 to 2010 151
Table 71: Specialty Pharmaceutical Market, Licensing Deals, GlaxoSmithKline, 2004 to 2010 153
Table 72: Specialty Pharmaceutical Market, Co-development Deals, Pfizer, 2004-2010 156
Table 73: Specialty Pharmaceutical Market, Co-development Deals, F. Hoffmann-La Roche, 2004-2010 158
Table 7
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |